Anna Chen is a strategic planning professional with extensive experience in the healthcare and biotechnology sectors. Currently at Abbott, Anna spearheads long-range planning workshops for a $7B diabetes portfolio and drives alignment among interdisciplinary teams on key industry matters. Previously, at Guardant Health, Anna served as the Associate Director of New Products, where a successful go-to-market strategy for a diagnostic platform generated $38M in sales within the first year. Additional roles include Senior Manager of Business Development at Guardant Health, Associate Consultant at McKinsey & Company, and multiple positions at the University of Chicago, where Anna contributed to research on skeletal muscle metabolism and innovation funding for biotech startups. Anna holds a Ph.D. in Molecular Metabolism and Nutrition from the University of Chicago and has completed MBA coursework at the University of Chicago Booth School of Business.
This person is not in the org chart
This person is not in any teams
This person is not in any offices